1 published article · Updated continuously
10 trials tracked for Procedural Pain: 5 in phase 3 or 4 and 3 with published results. The most-cited published study has 9 citations.
Showing the 10 most-cited and recently-updated of 10 trials. Browse the full registry →
Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.
Pharmacological interventions have been evaluated for procedural pain management. The administration of Ropivacaine 0.2% injectable solution was associated with a significant reduction in the total amount of opioid medications administered (p=0.004) 4.
Local anesthetic agents, including Lidocaine 7 and a topical gel combination of LET Lidocaine (4%), Epinephrine (0.1%), and Tetracaine (0.5%), have been utilized in clinical settings [5, 7]. Additionally, Buprenorphine 0.15 MG was evaluated for pain management during osmotic dilator insertion, with reported pain scores at the time of insertion ranging from 3.0 to 4.0 and decreasing or remaining low at one and two hours post-insertion 6.
AI synthesis of 5 cited trials, updated Jul 3, 2026. Informational only — not medical advice; trial data sourced from ClinicalTrials.gov. How we use AI.
